DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.17
+0.95 (18.20%)
Aug 13, 2025, 12:13 PM - Market open
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $318.92 million as of August 13, 2025. Its market cap has increased by 130.77% in one year.
Market Cap
318.92M
Enterprise Value
240.07M
1-Year Change
130.77%
Ranking
Category
Stock Price
$6.17
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $318.92M, an increase of 768.99%. That is a compound annual growth rate of 38.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 223.90M | -3.57% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
| Dec 7, 2018 | 36.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |